↓ Skip to main content

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Overview of attention for article published in Advances in Therapy, April 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
90 Mendeley
Title
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Published in
Advances in Therapy, April 2019
DOI 10.1007/s12325-019-00943-4
Pubmed ID
Authors

Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Michael Reusch, Toshihiro Misumi

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 90 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 12%
Other 10 11%
Student > Ph. D. Student 7 8%
Researcher 7 8%
Student > Postgraduate 6 7%
Other 16 18%
Unknown 33 37%
Readers by discipline Count As %
Medicine and Dentistry 37 41%
Biochemistry, Genetics and Molecular Biology 5 6%
Engineering 3 3%
Nursing and Health Professions 2 2%
Unspecified 2 2%
Other 7 8%
Unknown 34 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2019.
All research outputs
#14,445,514
of 23,140,503 outputs
Outputs from Advances in Therapy
#1,124
of 2,387 outputs
Outputs of similar age
#195,992
of 352,213 outputs
Outputs of similar age from Advances in Therapy
#29
of 58 outputs
Altmetric has tracked 23,140,503 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,387 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,213 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.